LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medlab Middle East Sees 100% Increase in Exhibitor Numbers

By LabMedica International staff writers
Posted on 16 Jan 2023
Print article
The focus on technology and sustainability has seen unprecedented demand from exhibitors (Photo courtesy of Informa Markets)
The focus on technology and sustainability has seen unprecedented demand from exhibitors (Photo courtesy of Informa Markets)

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, has sold out its exhibitor space ahead of the show, which returns to the Dubai World Trade Centre from February 6 to 9, 2023.

The latest statistics from the Medlab Middle East organizer, Informa Markets (London, UK), reveal that the number of exhibition halls is up from four to six, with a total of 31,000 sq. mt. of space. Over 350 new exhibitors have been confirmed, taking the total to more than 700, with 180 countries represented, marking a 100% increase as compared to the 2022 edition of the show. Additionally, international pavilions have also increased from 11 to 14.

In line with the Medlab Middle East theme, ‘paving the way for technological advancements and sustainability in laboratory medicine’, various exhibitors will showcase their latest products in fields such as disposables, imaging, IT systems, and medical equipment, among others, contributing to the rise in exhibitor numbers. Apart from a full line-up of exhibitors on the show floor, Medlab Middle East will launch its Hosted Buyer program, which will match exhibitors with senior decision-makers belonging to the healthcare industry. The show floor will also offer a series of seminars and workshops to allow visitors to learn first-hand about the latest medical laboratory innovations from the exhibitors.

At Medlab Middle East, the newly-launched Labpreneur competition will invite promising diagnostic start-up companies to pitch groundbreaking ideas that can transform the laboratory market to a panel of experts who will select the winner on the final day of the exhibition. This year, the Medlab Middle East Congress will also return, providing education and solutions to advance laboratory skills and improve laboratory functions to over 5,000 conference delegates. With 12 conferences, the Congress is the largest CME-accredited multi-track medical laboratory congress in the world, featuring 130+ local and international speakers. This year's conference program will include eight core lab conference tracks, with further four new additions addressing Point of Care Testing (POCT), Tech Advances and Clinical Impact, New trends in laboratory medicine, Quality Management in the Lab, and Sustainability in the Lab. For the first time, Medlab Middle East will showcase a new Entertainment zone – The Village, which will provide a more relaxed environment to the attendees for networking.

“It has been an incredible year of growth for the medical laboratory industry and Medlab Middle East. This year we will welcome 650 exhibitors from 180 countries, many of whom are making their debut at the event by highlighting the latest technological advances on the market,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “We are also welcoming back several of our Asian counterparts who have been unable to travel due to restrictions in their home countries as well as stalwarts of the event Abbott, Biomerieux, Beckman Coulter, Randox, illumina, bioMérieux, Randox and Mindray, amongst others.”

 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Sekisui Diagnostics UK Ltd.